Heart Failure

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC66-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Document the HF-specific skilled surveillance and management each day:

  • Daily weight against the prior value and the dry-weight/target, with the trend; edema (location and grade) and its change.
  • Congestion signs: lung sounds (bibasilar crackles), jugular venous distension, a new S3, orthopnea/paroxysmal nocturnal dyspnea, and exertional dyspnea.
  • GDMT tolerance (blood pressure and heart rate against parameters, renal function and potassium from labs) and the diuretic response; sodium and fluid adherence.

MDS-supportive data

Cardiac medication and anticoagulant days are coded in MDS Section N, weight in Section K, IV medication in Section O, dyspnea/edema in Section J, and the HF diagnosis in Section I. The record must document the daily weight, the medication response, and the congestion assessment so the MDS is supported.

Section NavigationPart 3 of 15PreviousNext